REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
17/11/2025
Voltar para busca
Dado oficial do USPTO
LOKAVANT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
21
Atualização mais recente
18/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
22/11/2019
Data de registro
17/11/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/11/2020
Última transação
18/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
NEW YORK, NY
Examinador
KETCHUM,BRENDAN J
Unidade examinadora
N70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
LOKAVANT, INC.
Roivant Sciences GmbH
Representantes
Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Advertising services; business management; business administration services; providing office functions; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; artificial intelligence and machine learning statistical analysisconsultancy and reporting for pharmaceutical and biomedical research for business purposes; business analysis and statistical analysis of healthcare datapharmaceuticalsbiomedical researchfor clinical trial and post-market data for business purposes; systematization and compilation of data in computer databasesin particular compilation of information into computer databases for research and analysis purposes in the field of healthcarepharmaceuticalsbiomedicinepharmaceutical and biomedical research and developmentclinical trials and post-market data; professional business analysis and consultancy and statistical analysis in the fields of healthcarepharmaceuticalsbiomedicineclinical trialsepidemiological researchpharmacoepidemiological researchpost-market trials and research evaluating epidemiological outcomes
Classe 42
Scientific and technological servicesmedical researchscientific research and analysis in the field of pharmaceuticals and biomedicine; analysis of technical data by computerscomputer modeling services; pharmaceuticalbiomedicalbiological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticalsbiomedicineclinical trials and post-market trials; cloud computing featuring software for compilingaccessingcontrollingmanaging and providing updated scientificpharmaceuticalmedical and clinical informationnews of general interest; cloud computing featuring software for conducting scientific research and analysis in the fields of public healthhealthcarepharmaceutical and biomedical researchclinical trial data and data from examinations carried out after the introduction of medicines on the market; cloud computing featuring software for providinganalyzing and generating reportsfor data processingfor the capturecollectionconversionanalysiscommunicationprocessingreceivingrecordingstorage and/or transmission of dataimages and informationfor the conversionanalysisprocessingstorage and transmission of artificial intelligencefor database integrationfor creating searchable databases of information and datafor analytics in the fields of healthcarepharmaceuticalsbiomedicinepharmaceutical and biomedical research and developmentfor clinical trial and post-market trial datafor managing and analyzing clinical trial and clinical research workflowfor use in collecting and managing data in the field of biomedical researchfor biomedical and clinical research servicesfor database management software for use in biomedical and clinical and medical research; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticalsbiomedicinepharmaceutical and biopharmaceutical research and developmentmedical informationclinical trial and post-market trial data; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compilingaccessingcontrollingmanaging and providing updated scientificpharmaceuticalmedical and clinical informationnews information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analyticsfinancial analytics and risk management for use in the fields of pharmaceutical and biomedical research and developmentclinical trialsthe provision of medical and healthcare services; application service provider featuring software for collectingprocessingstoringextractinganalyzing and transmitting clinical research data
Publicações
Histórico de despachos e eventos da marca no USPTO.
21 publicações encontradas
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/08/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
17/11/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/09/2020
PUBO
PUBLISHED FOR OPPOSITION
01/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/08/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
21/07/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
17/07/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
10/07/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
26/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/12/2019
GNRT
NON-FINAL ACTION E-MAILED
20/12/2019
CNRT
NON-FINAL ACTION WRITTEN
20/12/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
18/12/2019
DOCK
ASSIGNED TO EXAMINER
18/12/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2019
NWAP
NEW APPLICATION ENTERED
26/11/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LOKAVANT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.